Mortality in joggers: population based study of 4,658 men.

tures in patients with primary hyperparathyroidism. Arch Intern Med 1992;152:2269-73. 12 Peacock M, Horsman A, Aaron JE, Marshall DH, Selby PL, Simpson M. The role of parathyroid hormone in bone loss. In: Christiansen C, Arnaud CD, Nordin BEC, Parfitt AM, Peck WA, Riggs BL, eds. Osteoporosis. Glostrup: Department of Clinical Chemistry, Glostrup Hospital, 1984:463-7. 13 Larsson K, Lindh E, Lind L, Persson I, Ljunghall S. Increased fracture risk in hypercalcemia: bone mineral content measured in hyperparathyroidism. Acta Orthop Scand 1989;60:268-70. 14 Kochersberger G, Buckley NJ, Leight GS, Martinez S, Studenski S, Vogler J,et al.What is the clinical significance of bone loss in primary hyperparathyroidism? Arch Intern Med 1987;147:1951-3. 15 Larsson K, Ljunghall S, Krusemo UB, Naessen T, Lindh E, Persson I. The risk of hip fractures in patients with primary hyperparathyroidism: a population-based cohort study with a follow-up of 19 years. J Intern Med 1993;234:585-93. 16 Khosla S, Melton III LJ, Wermers RA, Crowson CS, O’Fallon WM, Riggs BL. Primary hyperparathyroidism and the risk of fracture: a populationbased study. J Bone Mineral Res 1999;14:1700-7. 17 Mellemgaard A, Jørgensen J. Sygdomsmønstret for indlagte patienter og ambulante patienter 1995. Sundhedsstatistikken 1997:5. Copenhagen: National Board of Health, 1997:1-271. 18 Christiansen P, Steiniche T, Brixen K, Hessov I, Melsen F, Heickendorff L, et al. Primary hyperparathyroidism: short term changes in bone remodeling and bone mineral density following parathyroidectomy. Bone 1999;25:237-44. 19 Cummings SR, Nevitt MC, Browner WS, Stone K, Fox KM, Ensrud KE, et al. Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. N Engl J Med 1995;332:767-73. 20 Black DM, Cummings SR, Kerpf DB, Cauley JA, Thompson DE, Nevitt MC, et al. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Lancet 1996;348:1535-41.